Showing results (1181-1190 of 2,357) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|February 28, 2022
Clinical Management of Sleep and Sleep Disorders With Cannabis and Cannabinoids: Implications to Practicing PsychiatristsJaime M Monti, Seithikurippu R Pandi-PerumalClinical Neuropharmacology|February 1, 1988
Deprenyl in the treatment of symptom fluctuations in advanced Parkinson's diseaseL I Golbe, A N Lieberman, M D Muenter, et al.Clinical Neuropharmacology|January 1, 1987
Effect of valproic acid therapy on zinc metabolism in children with primary epilepsyT Lerman-Sagie, M Statter, G Szabo, et al.Clinical Neuropharmacology|June 1, 1987
Effects of dopamine antagonists and apomorphine on regional energy metabolism in rat CNSP M Carvey, A R Braun, L C Kao, et al.Clinical Neuropharmacology|June 1, 1987
Carbamazepine and carbamazepine-10,11-epoxide inhibit amygdala-kindled seizures in the rat but do not block their developmentS R Weiss, R M PostClinical Neuropharmacology|October 6, 2000
Reversible pitch perception deficit caused by carbamazepineT Miyaoka, H Seno, M Itoga, et al.Clinical Neuropharmacology|October 6, 2000
Nefazodone in the adjunctive therapy of schizophrenia: an open-label exploratory studyP B Rosenberg, R B Rosse, B L Schwartz, et al.Clinical Neuropharmacology|October 12, 1999
Modification of dopamine D2 receptor activity by pergolide in Parkinson's disease: an in vivo study by PETG Linazasoro, J A Obeso, J C Gómez, et al.Clinical Neuropharmacology|October 12, 1999
Fulminant CNS perivascular lymphocytic proliferation: association with sargramostim, a hematopoietic growth factorJ E Riggs, P T Mansmann, L L Cook, et al.Pageof 236